These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1352574)

  • 1. Protein processing in lysosomes: the new therapeutic target in neurodegenerative disease.
    Mayer RJ; Landon M; Laszlo L; Lennox G; Lowe J
    Lancet; 1992 Jul; 340(8812):156-9. PubMed ID: 1352574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomes as key organelles in the pathogenesis of prion encephalopathies.
    Laszlo L; Lowe J; Self T; Kenward N; Landon M; McBride T; Farquhar C; McConnell I; Brown J; Hope J
    J Pathol; 1992 Apr; 166(4):333-41. PubMed ID: 1355530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
    Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
    PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multivesicular body is the major internal site of prion conversion.
    Yim YI; Park BC; Yadavalli R; Zhao X; Eisenberg E; Greene LE
    J Cell Sci; 2015 Apr; 128(7):1434-43. PubMed ID: 25663703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin, cellular inclusions and their role in neurodegeneration.
    Alves-Rodrigues A; Gregori L; Figueiredo-Pereira ME
    Trends Neurosci; 1998 Dec; 21(12):516-20. PubMed ID: 9881849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice.
    Nakagaki T; Satoh K; Ishibashi D; Fuse T; Sano K; Kamatari YO; Kuwata K; Shigematsu K; Iwamaru Y; Takenouchi T; Kitani H; Nishida N; Atarashi R
    Autophagy; 2013 Sep; 9(9):1386-94. PubMed ID: 23800841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
    Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.
    Kitamoto T; Shin RW; Doh-ura K; Tomokane N; Miyazono M; Muramoto T; Tateishi J
    Am J Pathol; 1992 Jun; 140(6):1285-94. PubMed ID: 1351366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for lysosomes in scrapie pathogenesis.
    Kenward N; Laszlo L; Landon M; Fergusson J; Lowe J; McDermott H; Hope J; Brown J; Mayer RJ
    Biochem Soc Trans; 1992 Aug; 20(3):265S. PubMed ID: 1358723
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysosomal Acid Phosphatase Biosynthesis and Dysfunction: A Mini Review Focused on Lysosomal Enzyme Dysfunction in Brain.
    Ashtari N; Jiao X; Rahimi-Balaei M; Amiri S; Mehr SE; Yeganeh B; Marzban H
    Curr Mol Med; 2016; 16(5):439-46. PubMed ID: 27132795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endosome-lysosomes, ubiquitin and neurodegeneration.
    Mayer RJ; Tipler C; Arnold J; Laszlo L; Al-Khedhairy A; Lowe J; Landon M
    Adv Exp Med Biol; 1996; 389():261-9. PubMed ID: 8861020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.
    Gowrishankar S; Yuan P; Wu Y; Schrag M; Paradise S; Grutzendler J; De Camilli P; Ferguson SM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):E3699-708. PubMed ID: 26124111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-hydroxytamoxifen leads to PrPSc clearance by conveying both PrPC and PrPSc to lysosomes independently of autophagy.
    Marzo L; Marijanovic Z; Browman D; Chamoun Z; Caputo A; Zurzolo C
    J Cell Sci; 2013 Mar; 126(Pt 6):1345-54. PubMed ID: 23418355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the role of dendritic cells in prion transfer to primary neurons.
    Langevin C; Gousset K; Costanzo M; Richard-Le Goff O; Zurzolo C
    Biochem J; 2010 Oct; 431(2):189-98. PubMed ID: 20670217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin and the lysosome system: molecular immunopathology reveals the connection.
    Mayer RJ; Lowe J; Landon M; McDermott H; Tuckwell J; Doherty F; László L
    Biomed Biochim Acta; 1991; 50(4-6):333-41. PubMed ID: 1666279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.